MetaCap

Neuropace Statistics

NASDAQ: NPCEHealth CareMedical/Dental InstrumentsUSD

7.95-0.19 (-2.33%)

At close: Nov 20, 4:00 PM ET · Delayed 15 min

Neuropace by the numbers

Neuropace has a market capitalization of $273.9 million based on 34.45M shares outstanding. With trailing EPS of $-0.56, Neuropace is unprofitable on a 12-month basis, so earnings-based valuation ratios do not apply. The stock trades 36.8% below its 50-day average and 45.4% below its 200-day average.

Average daily trading volume is 270.76K shares, or about $2.2 million in dollar volume.

Summary generated from market data by MetaCap's automated system. Methodology

NPCE valuation vs. peer median

NPCE compared with the median of 8 peer companies
MetricNPCEPeer medianDifference
Market cap$273.89M$251.14M+9%
Avg. volume270.76K374.14K-28%

Peer median across 8 companies: TMCI, INFU, SSII, OFIX, OSUR, PROF, CLPT, EMBC.

Valuation

Market cap
$273.89M
Price / sales (latest FY)
2.74
EPS (TTM)
$-0.56

Price and trading

Previous close
8.14
Open
7.97
Day range
7.85 – 8.29
52-week range
5.46 – 19.60
52-week change
-44.60%
Beta
—
Volume
749.38K

Dividends and events

Annual dividend
None
Next earnings date
Nov 12, 2026

Additional statistics

Market Cap
273.89M
Forward Pe
-21.42
Eps
-0.56
Dividend Yield
0.00%
Dividend Rate
0.00
Week52 High
19.60
Week52 Low
5.46
Avg Volume
270.76K
Shares Outstanding
34.45M
Ma50
12.57
Ma200
14.57
Earnings Date
Nov 12, 2026
Pct From52w High
-59.44%
Pct From52w Low
45.60%

Related